In The News Posted January 31, 2019 Share Posted January 31, 2019 NEW YORK, Jan. 31, 2019 /PRNewswire/ -- Genomic Prediction, developer of the world's first and only polygenic disease screening tests for improving IVF health outcomes, announced today that it has raised $4.5 million through the sale of preferred stock. Nimble Ventures led the... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.